Chapter 8: Study of Suicide Risk in Different Mental Disorders and Comorbidities

Four-Layer Interaction Framework Positioning: This chapter serves as an application validation of the book's four-layer framework. The preceding four chapters (Chapters 4 to 7) revealed the biological mechanisms of mental disorders from genetic, developmental, metabolic, and systemic levels, respectively; this chapter focuses these mechanisms on the most severe clinical outcome: suicide. Suicide risk data are not isolated statistical figures, but rather the ultimate manifestation of the imbalance in the four-layer interaction. The differences in suicide risk among various mental disorders reflect the specificity of their four-layer interaction patterns.

8.1 Suicide is a Symptom of Mental Disorders, Not a "Failure to Think Things Through"

At the very beginning, we already presented that cold fact: approximately 90% of those who die by suicide suffered from one or more diagnosable mental disorders before their death. More than half of suicide decedents suffered from MDD or BD. This set of data is the cornerstone of understanding the phenomenon of suicide—it directly drags suicide back from ethereal social prejudices such as "unable to see the light," "impulsive moments," or "fragile character," onto the realistic battlefield of psychiatry and neuroscience.

But simply knowing that "90% of suicide decedents have mental disorders" is not enough. We also need to understand: the suicide risks of different mental disorders are poles apart; and under the same diagnosis, the risks of different individuals also vary drastically. Behind this, it is not a difference in "willpower," but has a clear biological logic.

Stress-Diathesis Model: Why Doesn't Everyone Who Encounters Misfortune Die by Suicide?

To understand the difference in suicide risk, the most fundamental theoretical framework is the "Stress-Diathesis Model". This model posits that suicidal behavior is the result of the interaction between pre-existing neurobiological diathesis and acute environmental stressors.

The so-called "diathesis" includes traits such as aggression, impulsivity, learned helplessness, and altered decision-making ability. These diatheses have clear neurobiological foundations—functional deficits in the prefrontal cortex, low activity of the 5-HT system, hyperactivity of the HPA axis, chronification of neuroinflammation... They are not "character flaws," but rather biological states of the brain.

The so-called "stress" refers to sudden psychosocial crises—unemployment, bereavement, divorce, medical diagnosis... These events themselves do not directly cause suicide, but rather manifest potential vulnerability as actual suicidal behavior by activating those pre-existing biological diatheses.

This model explains a key question: Why is it that not all individuals facing stress or suffering from mental illness ultimately choose suicide? Because their diatheses are different. Faced with the same unemployment, a person with a normally functioning prefrontal cortex and a well-operating 5-HT system might experience a period of low mood and then stand back up; whereas a patient with low white matter integrity in the prefrontal cortex and lower levels of 5-HT metabolites might rapidly slide from despair into suicide.

"Agitation + Despair": Why is the Suicide Risk of BD Far Higher Than That of Unipolar Depression?

A seemingly contradictory phenomenon is worth in-depth analysis: major depressive disorder (MDD) is the most common diagnosis among suicide decedents (accounting for about 46%), but the standardized mortality ratio (SMR) of MDD is only around 3.1; whereas BD accounts for a smaller proportion of suicide decedents than MDD, but its SMR is as high as 10-15, and 15-20% of BD patients eventually die by suicide.

Why? The core mechanism lies in the mixed state of "agitation + despair."

Generally speaking, patients with depression merely feel they have lost the meaning of life, and severely depressed patients often lack the capacity for action due to somatic symptoms—they want to die, but cannot execute it. However, when BD patients are in a mixed episode, they possess both the negative thoughts of losing the meaning of survival under a depressive episode, and the capacity for agitated and impulsive action under a manic episode. The dangerous combination of these two forces enables BD patients not only to have a strong desire for suicide but also to possess the ability to put it into practice.

This also explains why the suicide mortality rate of substance use disorders is so high—alcohol and drugs similarly create a state of "agitation + despair": the substances themselves impair judgment and impulse control, worsening feelings of despair and agitation, while the acute intoxication and withdrawal phases represent high-risk moments for suicide.

8.2 Quantitative Stratification of Suicide Risk Across Different Disorders

The following data are synthesized from multiple systematic reviews, meta-analyses, and large-scale cohort studies. Quantitative indicators include the standardized mortality ratio (SMR), adjusted hazard ratio (aHR), suicide rate per person-year, and odds ratio (OR). Of particular note is a Korean national cohort study published in Molecular Psychiatry in 2025 (3.95 million individuals, average follow-up of 11.1 years), which provided the largest-scale comparative data on suicide risk across various mental disorders to date (Kim et al., 2025).

Extremely High-Risk Group

Anorexia Nervosa (SMR 18-31 times)

The suicide risk of anorexia nervosa ranks first among all mental disorders. Approximately one-fifth of deaths from anorexia nervosa are due to suicide, making suicide the second leading cause of death after complications. This extremely high risk cannot be explained solely by comorbidities (such as depression). The core symptoms of anorexia nervosa—chronic starvation, extreme dieting, and self-punishment (vomiting, excessive exercise)—may increase tolerance to physical pain and diminish the fear of death. This "acquired tolerance" makes their suicide attempts more lethal. In subtypes with binge-eating/purging behavior, the lifetime suicide attempt rate is as high as 44.1%.

Borderline Personality Disorder (SMR 45.1, aHR 7.70)

The SMR of BPD is as high as 45.1, and its aHR of 7.70 ranks first among all 14 categories of mental disorders (Kim et al., 2025). A 2025 meta-analysis (Lak et al., 2025) showed: a lifetime suicidal ideation rate of 80%, a lifetime suicide attempt rate of 52%, and a suicide mortality rate of 6%. The core symptoms of BPD—intense affective dysregulation, impulsivity, and chronic suicidal ideation—are the primary drivers of high risk. Crucially, BPD is almost always comorbid with other mental disorders, and this comorbidity further amplifies the suicide risk. A detailed analysis of personality disorders as suicide risk amplifiers can be found in Section 8.3.

High-Risk Group

Schizophrenia (SMR 13.03, aHR 5.91)

The suicide risk of schizophrenia is not uniformly distributed throughout the course of the illness. The peak risk periods are concentrated at: the early stage of onset, after the first psychotic episode, and when symptoms are partially relieved but the patient begins to gain insight into their own illness. They may choose suicide due to feelings of despair regarding the prognosis of the disease, deterioration of social functioning, and fear of future worsening. About 5% of patients with schizophrenia eventually die by suicide.

Bipolar Disorder (SMR 10.26, aHR 6.05)

Up to 15-20% of BD patients eventually die by suicide. Their unique "mixed episode" or "rapid cycling" states dangerously combine manic impulsivity with depressive despair. The lethality of suicide attempts in BD patients is also higher than that in MDD patients, reflecting the impulsive and lethal tendencies in their suicidal behavior. The Korean cohort data showed that the suicide aHR for BD was 6.05, second only to personality disorders.

Substance Use Disorders (Risk Ratio 10-14 times) and Alcohol Use Disorder (SMR 6.78, aHR 4.43)

The correlation between different substances and suicide risk varies: the HR for sedative use is 11.36, and it can reach 13.5 times for heroin. The OR for acute alcohol use can be as high as 6.97. Substances themselves impair judgment and impulse control, worsening despair and agitation; high-risk moments for suicide typically occur during acute intoxication and withdrawal. The Korean cohort study showed that the suicide aHR was 4.43 for alcohol use disorder and 4.53 for drug use disorders.

Obsessive-Compulsive Disorder (OCD) (Suicide risk increased by nearly 5 times, aHR 4.66)

The suicide risk of OCD has long been underestimated. A Swedish national matched cohort study published in the BMJ in 2024 (61,378 OCD patients vs 613,780 matched controls) found that patients with OCD had an 82% increased risk of all-cause mortality, of which the suicide risk was increased by nearly 5 times (Meier et al., 2024). The Korean cohort study also confirmed a suicide aHR of 4.66 for OCD. A 2024 longitudinal study in Taiwan further found that even after controlling for major psychiatric comorbidities (depression, BD, schizophrenia), the suicide risk of OCD remained significant (HR 1.97, 95% CI: 1.57-2.48), and OCD severity was positively correlated with suicide risk.

The suicide risk of OCD has long been neglected, partly due to the concealment of its symptoms—OCD is notorious for secrecy and shame, and many patients do not actively report suicidal ideation. Clinical studies show that the lifetime suicidal ideation rate of OCD patients is as high as 64.3%, and the lifetime suicide attempt rate is 16.3% (Bramante et al., 2023).

Moderate-Risk Group

Major Depressive Disorder (Rate: 534.3/100,000 person-years, aHR 2.98)

MDD is the most prevalent risk factor for suicide and is the most common known diagnosis among all suicide deaths (accounting for about 46%). Although its SMR is not as extreme as that of BPD or anorexia, due to its high prevalence, it has a massive impact on public health. The suicide risk of MDD rises with the severity of the illness, particularly when accompanied by severe anxiety, impulsivity, or psychotic symptoms. The Korean cohort study showed a suicide aHR of 2.98 for MDD—interestingly, this value is far lower than those for personality disorders (7.70), BD (6.05), and schizophrenia (5.91), overturning the public impression that "depression equals suicide."

Post-Traumatic Stress Disorder (HR: 6.74 for females, 3.96 for males; aHR 3.37)

The correlation between PTSD and suicide risk persists even after controlling for other comorbidities (such as depression and substance use disorders). Its risk may be related to symptoms unique to trauma, such as intrusive memories, anger, and impulsivity. The Korean cohort data showed a suicide aHR of 3.37 for PTSD.

Attention-Deficit/Hyperactivity Disorder (ADHD)

The suicide risk of ADHD has long been underestimated. Although ADHD itself does not directly lead to high suicide rates, its core symptoms—impulsivity and executive dysfunction—significantly increase the risk of suicidal behavior. More importantly, ADHD is an "upstream" risk factor for multiple mental disorders. Its high comorbidity rates with substance use disorders, BD, and BPD make it indirectly amplify suicide risk. The suicide attempt rate of adult ADHD patients is approximately 3-5 times that of the general population.

Comorbidities and Auxiliary Risk Group

Generalized Anxiety Disorder (GAD)

Anxiety disorders alone are weak predictors of suicide deaths (OR of only 1.01), but as comorbid factors, they significantly amplify the suicide risk of other disorders. Compared to patients suffering from depression alone, patients suffering from both GAD and depression have a three-fold higher suicide risk.

Insomnia Disorder

Insomnia has been identified as an independent, modifiable suicide risk factor, which can increase the suicide risk of patients with MDD by 1.71 times. Insomnia is not only a symptom of depression; it may also independently increase suicide risk by exacerbating feelings of despair and impairing executive function and impulse control.

Unspecified Eating Disorder

Even for eating disorder subtypes that do not meet specific diagnostic criteria, their suicide risk is 4 times that of the general population.

Summary of Quantitative Indicators

Table 8-1. Overview of Quantitative Indicators of Suicide Risk Across Various Mental Disorders

Mental Disorder	Type of Quantitative Indicator	Core Data Value	Risk Level	Primary Source
Borderline Personality Disorder	SMR / aHR	45.1 / 7.70	Extremely High Risk	DSM-5 Meta-analysis; Kim et al., 2025
Anorexia Nervosa	SMR	18-31 times	Extremely High Risk	Arcelus et al., 2011
Schizophrenia	SMR / aHR	13.03 / 5.91	High Risk	Pompili et al.; Kim et al., 2025
Bipolar Disorder	SMR / aHR	10.26 / 6.05	High Risk	Tidemalm et al.; Kim et al., 2025
Substance Use Disorders	Risk Ratio / aHR	10-14 times / 4.53	High Risk	Wilcox et al.; Kim et al., 2025
Alcohol Use Disorder	SMR / aHR	6.78 / 4.43	High Risk	Pompili et al.; Kim et al., 2025
Obsessive-Compulsive Disorder (OCD)	HR / aHR	~5 times / 4.66	High Risk	Meier et al., 2024; Kim et al., 2025
Major Depressive Disorder	Rate per person-year / aHR	534.3/100,000 / 2.98	Moderate Risk	Chesney et al.; Kim et al., 2025
Post-Traumatic Stress Disorder	HR / aHR	3.96-6.74 / 3.37	Moderate Risk	Gradus et al.; Kim et al., 2025
ADHD	OR	3-5 times	Moderate Risk	Systematic reviews
Generalized Anxiety Disorder	OR (Comorbidity Amplification)	3x amplification	Auxiliary Risk	Sareen et al.
Insomnia Disorder	OR	1.71	Auxiliary Risk	Bernert et al.
Unspecified Eating Disorder	Risk Ratio	4 times	Auxiliary Risk	Systematic reviews

8.3 Personality Disorders: Suicide Risk Amplifiers

Among all mental disorders, personality disorders occupy a special position in suicide risk: they are both independent extremely high suicide risk factors and "amplifiers" for the suicide risk of almost all other mental disorders. The conclusion of the 2025 Korean national cohort study (3.95 million individuals) is resounding: the suicide risk of personality disorders ranks first among 14 categories of mental disorders (aHR 7.70), surpassing Bipolar Disorder (6.05) and Schizophrenia (5.91), which are commonly perceived as the "most dangerous" by the public.

However, personality disorders are precisely the category of mental disorders that is most easily overlooked, most stigmatized, and most lacking in effective intervention in public perception and clinical practice.

The Three Clusters of Personality Disorders and Suicide Risk

DSM-5 classifies personality disorders into three main clusters (Cluster A/B/C), which have vastly different relationships with suicide risk:

Cluster B—Dramatic/Emotional/Erratic: The Core Cluster of Suicide Risk

Cluster B includes Borderline Personality Disorder (BPD), Antisocial Personality Disorder (ASPD), Narcissistic Personality Disorder (NPD), and Histrionic Personality Disorder (HPD). This cluster has the closest relationship with suicide risk.

• Borderline Personality Disorder (BPD): About 65-80% of BPD patients have experienced non-suicidal self-injury (NSSI), which is a strong predictor of suicidal behavior. The core drivers of BPD suicide risk include: affective dysregulation (extreme fluctuations and difficulty in regulating emotions), impulsivity (lack of premeditation and inhibition in behavior), fear of abandonment (extreme sensitivity to interpersonal rejection), and chronic feelings of emptiness (persistent existential void).

• Antisocial Personality Disorder (ASPD): The lifetime suicide attempt rate of ASPD patients is approximately 25%, and the suicide mortality rate is around 5%. Their suicide risk is primarily associated with impulsivity, aggressiveness, and substance abuse. A 2023 systematic review (McClelland et al., 2023) pointed out that suicidal behavior in ASPD is more associated with drug and alcohol use, and a history of interpersonal conflict.

• Narcissistic Personality Disorder (NPD): The relationship between NPD and suicide risk is highly complex and contradictory. A systematic review published in the Journal of Psychiatric Research in 2024 (Sprio et al., 2024) revealed a key distinction: vulnerable narcissism is associated with suicidal ideation, low-impulsivity self-harm, and deliberate self-harm; whereas grandiose narcissism is associated with severe self-harm and multiple highly lethal suicide attempts, but conversely has a protective effect against suicidal ideation. A 10-year follow-up study (Ansell et al., 2015) even found that NPD was the only personality disorder factor that predicted an increase in the number of suicide attempts—this effect remained significant even after controlling for other Cluster B disorders.

Cluster A—Odd/Eccentric: The Overlooked Risk

Cluster A includes Paranoid, Schizoid, and Schizotypal Personality Disorders. Research on the suicide risk of this cluster is relatively scarce, but existing data indicate that its risk should not be ignored. Schizotypal personality disorder has significant genetic overlap with schizophrenia, and its suicide risk may be underestimated. The suicide risk of paranoid personality disorder is associated with social isolation and persecutory delusions.

Cluster C—Anxious/Fearful: The Hidden Risk

Cluster C includes Avoidant, Dependent, and Obsessive-Compulsive Personality Disorders. The suicide risk in this cluster is often masked by anxiety symptoms. Avoidant personality disorder is associated with social avoidance and low self-esteem, which may indirectly increase suicide risk through social isolation. Notably, studies on elderly populations have found that obsessive-compulsive personality traits are associated with suicide deaths in older adults, but this association weakens after controlling for depression (Szücs et al., 2018).

Personality Disorders as Comorbid Suicide Risk Amplifiers

The most dangerous role of personality disorders is not as independent suicide risk factors, but rather as amplifiers of the suicide risk of other mental disorders.

BPD + MDD: 16-20 Times Amplification

For MDD patients with comorbid personality disorders, their suicide risk is an astonishing 16 times (for males) to 20 times (for females) higher than that of patients with MDD alone. This means that for a patient suffering from both BPD and depression, the suicide risk is not "1 + 1 = 2," but rather "1 + 1 = 16" or even more.

BPD + Substance Use Disorder: A Lethal Combination

The comorbidity rate of substance use disorders in BPD patients is as high as 40-70%. A 2024 study by Kaufman et al. found that among BPD suicide deaths, the number of comorbid diagnoses was significantly higher than that in non-BPD suicide deaths, with the comorbidity rate of PTSD being particularly prominent.

Personality Disorders + Any Axis I Disorder: Universal Amplification

A 2023 systematic review (McClelland et al., 2023) summarizing 34 studies pointed out that there is a consistent association between personality disorders and suicide attempts and/or suicide deaths. Historical interpersonal factors (such as childhood trauma), drug and alcohol use, and "ideation-to-action" transition factors are the core psychosocial mechanisms of suicide risk in personality disorders.

Biological Basis of Suicide Risk in Personality Disorders

The suicide risk of personality disorders is not the product of a "character flaw," but has a clear neurobiological basis:

• Genetic Layer: The heritability of BPD is approximately 40-60%. GWAS studies show significant genetic overlap between BPD and MDD, BD, and schizophrenia, particularly gene variants associated with impulsivity and affective instability.
• Developmental Layer: Childhood trauma is the strongest environmental risk factor for BPD. About 70% of BPD patients report a history of childhood sexual abuse, and about 90% report a history of childhood abuse/neglect. These traumas "program" a hyperactive HPA axis and dysfunctional attachment systems through epigenetic mechanisms.
• Metabolic Layer: BPD patients exhibit functional abnormalities in prefrontal-limbic circuits, particularly abnormal connectivity between the ventromedial prefrontal cortex and the amygdala. 5-HT system dysfunction is closely related to the impulsivity and aggressiveness of BPD.
• Social/Environmental Layer: The core feature of BPD—unstable interpersonal relationships—itself constitutes a continuous social and environmental stressor. Relationship conflicts caused by the fear of abandonment in turn exacerbate affective dysregulation, creating a vicious cycle.

Why Is the Suicide Risk of Personality Disorders Most Easily Overlooked?

Despite the fact that the suicide risk of personality disorders ranks first among all mental disorders, it is precisely the one most easily overlooked:

1. Double Stigmatization: Patients with personality disorders not only bear the stigma of "mental illness" but also the additional stigma of having a "character flaw." Many people—including some clinical workers—still view personality disorders as "attitude problems" rather than medical illnesses.

2. Underdiagnosis: Patients with personality disorders tend to attribute difficulties to the external environment rather than to themselves, and they rarely actively seek help. Korean researchers pointed out that although personality disorders affect about 10% of the general population, the proportion of those actually receiving a diagnosis is far lower.

3. Therapeutic Pessimism: For a long time, the clinical community has held a pessimistic attitude toward the treatment of personality disorders, believing they are "hard to change." However, evidence shows that Dialectical Behavior Therapy (DBT) is effective in reducing suicidal behavior in BPD, and a 10-year follow-up study showed that about 86% of BPD patients eventually no longer met the diagnostic criteria.

4. "Normalization" of Suicidal Behavior: Self-injury and suicide attempts in BPD patients are often viewed by clinical workers as "manipulative behavior" or "attention-seeking" rather than genuine signals of suicide risk. This misjudgment can lead to fatal consequences—suicide attempts in BPD patients are not always a "gesture," as proven by the 6% suicide mortality rate.

Table 8-2. Overview of Suicide Risk Across Personality Disorder Subtypes

Personality Disorder Subtype	Lifetime Suicide Attempt Rate	Suicide Mortality Rate	Core Risk Mechanism	Comorbidity Rate with Other Disorders
Borderline (BPD)	52%	6-10%	Affective dysregulation + impulsivity + fear of abandonment	Depression 70-96%, SUD 40-70%
Antisocial (ASPD)	~25%	~5%	Impulsivity + aggressiveness + substance abuse	SUD 70-90%
Narcissistic (NPD)	Limited data	Limited data	Vulnerable -> ideation; Grandiose -> high-lethality behavior	Depression, SUD
Schizotypal	Limited data	Limited data	Genetic overlap with schizophrenia	MDD, SUD
Avoidant	Limited data	Limited data	Social isolation + low self-esteem	MDD, GAD
Obsessive-Compulsive	Limited data	Higher risk in older adults	Perfectionism + need for control	MDD, OCD

8.4 Exponential Amplification Effect of Comorbidity

If the suicide risk of a single mental disorder is already alarming enough, the presence of comorbidities causes this risk to increase exponentially. Comorbidities among mental disorders do not simply add up the risks; instead, they generate an exponential amplification effect.

Geometric Relationship Between the Number of Diagnoses and Risk

A study targeting new recruits showed that with each additional mental disorder diagnosis, the odds ratio (OR) of suicidal ideation grew geometrically: from 3.1 times with a single diagnosis to 11.7 times with seven or more diagnoses. This strongly indicates that clinical treatment must adopt an integrative approach to handle all diagnoses simultaneously rather than just a single "primary" illness.

The Most Dangerous Comorbid Combinations

Substance Use Disorder + Depression

For male patients suffering from both SUD and MDD, the long-term suicide risk can be as high as 16.2%. Substance acts as a "catalyst" here—it impairs judgment, amplifies impulsivity, and intensifies despair, causing the already fragile defense line against suicide to collapse completely. In patients with borderline personality disorder, comorbid substance abuse significantly increases the frequency and severity of their suicidal behavior (for details on the amplification effect of personality disorder comorbidity, see Section 8.3).

Bipolar Disorder + Substance Use Disorder

This is one of the most common and dangerous comorbid combinations in clinical practice. BD itself already carries an extremely high suicide risk (impulsivity + despair under mixed episode states); when substance use is superimposed, the suicide risk skyrockets further. Studies have shown that BD patients with comorbid alcohol use disorder have a significantly higher rate of suicide attempts than non-comorbid patients.

Biological Logic of Comorbidity Amplification

The exponential amplification effect of comorbidity is not accidental. From the perspective of the four-layer interaction framework:

• Genetic Layer: Different mental disorders share a large number of risk genes. GWAS studies have confirmed significant genetic overlap among BD, schizophrenia, and MDD. Comorbid patients may carry more and higher density of risk gene variants.
• Developmental Layer: Different mental disorders may share abnormalities at key nodes along the developmental timeline. For example, childhood trauma is a risk factor for BPD, PTSD, and MDD simultaneously, and it "programs" a stress-response hyperactive HPA axis through epigenetic mechanisms.
• Metabolic Layer: Comorbidity implies disturbances in more neurotransmitter systems. Low 5-HT activity + dopamine dysfunction + enhanced glutamate excitability—this multi-transmitter imbalance is more destructive than a single transmitter abnormality.
• Social/Environmental Layer: Comorbidity itself exacerbates the deterioration of social functioning, forming a vicious cycle—the more severe the symptoms, the less social support is available, the greater the pressure, and the symptoms worsen further.

8.5 Neurobiological Basis of Suicide

Ideation and Action: The Dual-Circuit Model

Over the past two decades, 131 neuroimaging studies have revealed a key finding: suicidal ideation and suicidal behavior are two related yet distinct phenomena driven by different neural circuits.

Ventral Prefrontal Cortex (vPFC) — The "Engine" of Suicidal Ideation

The ventromedial prefrontal cortex (vmPFC) is closely related to the generation of suicidal ideation. Functional impairment in this region leads to excessive negative emotions, blunting of positive affect, and fosters a painful internal state, thereby prompting the formation of suicidal thoughts. The vPFC, working in concert with the amygdala, plays a key role in the experience of negative self-cognition and emotional pain.

Dorsal Prefrontal Cortex (dPFC) — The "Switch" from Ideation to Action

Unlike ideation, the dorsal prefrontal cortex (dPFC) is associated with the occurrence of suicidal behavior. Functional deficits in these regions lead to decreases in cognitive control, cognitive flexibility, and the ability to generate alternative solutions. This neural-level inflexibility lowers the threshold for putting suicidal ideation into action.

Anterior Cingulate Cortex (ACC) and Insula — The "Switcher" Translating Ideation into Behavior

The dorsal anterior cingulate cortex (dACC) and insula may play an important role in switching between the vPFC and dPFC systems, thereby facilitating the translation of suicidal ideation into behavior.

This means that the progression of suicide involves a dual-circuit model: one circuit (vPFC, amygdala) drives the painful state of ideation, while the other circuit (dPFC, ACC) is responsible for impulse and cognitive deficits, prompting the translation of ideation into action. Combined impairment of the vPFC and dPFC systems can lead to an extremely high-risk state—where there is both intense suicidal ideation and a lack of capability to inhibit action.

Neurotransmitter System Dysregulation

5-Hydroxytryptamine (5-HT) System: The Most Consistent Finding

Dysfunction of the 5-HT system is the most consistent neurobiological abnormality found in suicidal behavior. Reduced levels of its main metabolite, 5-hydroxyindoleacetic acid (5-HIAA), in the cerebrospinal fluid (CSF) is a well-documented finding in suicide attempters; its level correlates with the lethality of suicide attempts and predicts future risk.

Seemingly paradoxically, some studies have reported an increased number of 5-HT neurons and increased binding of certain receptors (such as 5HT1A and 5HT2A) in the brains of suicide victims. This can be explained by the homeostatic compensatory mechanism of the nervous system: the brain compensates for a chronically low-activity 5-HT system by upregulating receptor numbers. Therefore, these seemingly inconsistent findings actually portray a pathological adaptation process of the brain in response to insufficient 5-HT activity.

Glutamate and GABA: Excitatory-Inhibitory Imbalance

Neuroinflammation can activate the kynurenine pathway, leading to enhanced glutamatergic neurotransmission. This mechanism is supported by the remarkable efficacy of the NMDA receptor antagonist ketamine in rapidly reducing suicidal ideation—ketamine rapidly alleviates suicidal ideation by inhibiting the hyperexcited glutamatergic system.

Norepinephrine (NE) and Dopamine (DA)

Altered NE system function (reduced NE levels in the brainstem, increased α2-adrenergic receptor density) is associated with suicidal behavior. These changes are also considered homeostatic compensation in response to HPA axis hyperactivity and stress-induced NE depletion. Decreased DA function is associated with suicidal behavior in patients with depression.

Table 8-3. Core Neurotransmitter Systems Associated with Suicidal Behavior

Neurotransmitter System	Core Finding	Associated Behavioral Traits
5-Hydroxytryptamine (5-HT)	Reduced CSF 5-HIAA levels; prefrontal 5HT1A/5HT2A receptor upregulation; decreased transporter density	Impulsivity, aggressiveness, emotional dysregulation
Dopamine (DA)	Decreased functional levels	Mood disorders, impulsive behavior
Norepinephrine (NE)	Reduced brainstem levels; increased α2-receptor density	Anxiety, irritability, stress hyperreactivity
Glutamate and GABA	Enhanced glutamatergic neurotransmission; excitatory-inhibitory imbalance	Cognitive impairment, rapid anti-suicidal effect of ketamine

HPA Axis Hyperactivity and Neuroinflammation

HPA Axis: The Intersection of Distal Programming and Proximal Triggering

Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is one of the most consistent findings in suicidal patients. This manifests as elevated levels of cortisol and corticotropin-releasing hormone (CRH) in postmortem brains and CSF.

There is a key temporal dimension distinction here: early life adversity (ELA) is a distal vulnerability factor that "programs" a stress-response hyperactive HPA axis through epigenetic mechanisms—for example, suicide victims with a history of childhood abuse show increased methylation of the gene encoding the glucocorticoid receptor (NR3C1), leading to weakened negative feedback of the HPA axis. Conversely, recent life stress (RLS) is a proximal trigger, having a more direct, detectable impact on the HPA axis at the time of suicide.

This distinction refines the stress-diathesis model: only when the chronic biological "settings" (epigenetically programmed HPA axis hyperactivity) and the immediate "triggering" factors (acute stress events) act together can suicidal behavior ultimately occur.

Neuroinflammation: A Double-Edged Sword

Neuroinflammation is an emerging and highly watched field in the pathophysiology of suicide. Studies have found that both inflammatory hyperactivation and the loss of key protective mechanisms exist in the brains of suicide victims:

• Elevated inflammatory markers: Such as increased TSPO binding, and elevated levels of cytokines IL-6 and TNF-α.
• Weakened protective mechanisms: Such as a reduced number of oligodendrocytes, and decreased activity of the NPAS4 gene.

This is a "double-edged sword" pathology—the hyperactive "attack" and the "failure" of defense mechanisms together create a highly vulnerable brain environment. The efficacy of medications with anti-inflammatory properties, such as lithium and ketamine, in reducing suicidality further supports the causal role of neuroinflammation in suicidal behavior.

Neuroinflammation can also activate the kynurenine pathway and deplete tryptophan, leading to 5-HT depletion—which links inflammation, metabolism, and neurotransmitter systems together.

Genetic Susceptibility: Polygenic Architecture

Suicidal behavior has moderate heritability (30% to 55%), and this heritability is partially independent of major psychiatric syndromes. Unlike a single Mendelian trait, the genetic risk of suicide is polygenic, mediated collectively by many gene variants with minuscule effect sizes.

Epigenetic mechanisms provide a molecular basis for gene-environment interactions. In addition to the aforementioned methylation of the NR3C1 gene, the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene also exhibits gene-environment interaction effects—the low-expression 5-HTTLPR genotype amplifies the suicide risk associated with childhood trauma.

Table 8-4. Neurobiological Commonalities and Differences in Suicide Risk Across Different Mental Illnesses

Disease Type	Neurobiological Commonalities	Unique Neurobiological Associations
Major Depressive Disorder (MDD)	HPA axis hyperactivity; 5-HT dysfunction; reduced dmPFC/ACC white matter integrity	Specific reduction in dlPFC white matter integrity
Bipolar Disorder (BD)	HPA axis hyperactivity; 5-HT dysfunction; reduced dmPFC/ACC white matter integrity	Specific reduction in uncinate fasciculus (UF)/orbitofrontal cortex (OFC) white matter integrity; impulsive and cognitive traits
Schizophrenia	Low CSF 5-HIAA levels	Clozapine treatment efficacy; alterations in specific brain regions (ACC, insula)
Parkinson's Disease	Neurodegenerative pathology; high prevalence of depression	Dopamine system dysfunction; impact of therapeutic drugs
Huntington's Disease	Neurodegenerative pathology; high prevalence of depression and impulsivity	Neuropathy directly causing cognitive, emotional, and behavioral disorders

8.6 From "Coping Better" to "Scientific Prevention": Suicide Risk Under the Four-Layer Interaction Framework

Let us return to the core question of this book: how do we scientifically understand suicide?

Traditional societal views attribute suicide to "unable to see the light," "weak willpower," or "fragile character," with the corresponding "prevention" method being "cope better," "be stronger," or "think more about beautiful things." This moral-judgment-based "prevention" is completely useless for truly high-risk populations, and may even aggravate their stigma, making them even more afraid to seek help.

However, from the perspective of the four-layer interaction framework, the essence of suicide risk is:

$\text{自杀风险} = f(\text{遗传易感性} \times \text{发育时间线异常} \times \text{代谢紊乱} \times \text{社会环境压力})$

• Genetic Layer: Polygenic risk scores (PRS) determine your baseline vulnerability. The low-expression 5-HTTLPR genotype, BDNF Val66Met polymorphism, NR3C1 methylation state... these are not "character traits," they are genes.
• Developmental Layer: Childhood trauma programs a hyperactive HPA axis through epigenetic mechanisms; the alignment of the adolescent endocrine storm with the peak ages of BD onset (17 and 26 years old) is not a coincidence; myelination of the prefrontal cortex is not completed until around age 25, which explains why adolescents and young adults have weaker impulse control.
• Metabolic Layer: Low 5-HT activity, enhanced glutamate excitability, hyperactive HPA axis, neuroinflammation... these metabolic-level disturbances are the direct biological basis of suicidal ideation and behavior. The rapid anti-suicidal effect of ketamine is precisely achieved by modulating the glutamatergic system at the metabolic level.
• Social/Environmental Layer: Unemployment, bereavement, domestic violence, social isolation... these are not tests of "psychological resilience," but acute blows to an already vulnerable biological system. The impact of the same social stress on a person with a normal HPA axis and a person with a hyperactive HPA axis is poles apart.

Understanding this, the direction of suicide prevention is no longer "coping better," but rather:

1. Identify genetic susceptibility: Utilizing genomics tools to identify high-risk individuals and achieve early warning.
2. Focus on developmental timelines: Strengthening monitoring at key developmental nodes such as adolescence, postpartum, and menopause.
3. Correct metabolic dysregulation: Intervening directly in the biological basis of suicide through drug treatments (such as lithium, ketamine) and neuromodulation techniques (such as TMS, DBS).
4. Alleviate social and environmental stress: Restricting access to lethal means of suicide, strengthening social support, and reducing stigma—this is not "psychological comfort," but reducing acute blows to a vulnerable biological system.

Suicide is not a "failure to think things through," but a brain dysfunction. Understanding the science of mental disorders is the very science of suicide prevention.

Starting from the next chapter, we will unfold the four-layer interaction framework layer by layer, from genetic mutations to the social environment, systematically revealing the scientific essence of mental disorders.